✦ LIBER ✦

Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia

✍ Scribed by D. M. ARNOLD; S. SANTOSO; A. GREINACHER; ON BEHALF OF THE PLATELET IMMUNOLOGY SCIENTIFIC SUBCOMMITTEE OF THE ISTH

Book ID: 114754712
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 74 KB
Volume: 10
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2012.04664.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interference of IgG, IgG aggregates and

Interference of IgG, IgG aggregates and immune complexes in tests for platelet autoantibodies

✍ F. M. Helmerhorst; R. J. T. Smeenk; C. E. Hack; C. P. Engelfriet; A. E. G. Kr. v 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Misleading hepatitis B test results due

Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia

✍ Donald M. Arnold; Mark A. Crowther; Ralph M. Meyer; Julie Carruthers; Julie DiTo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Effects of anti-platelet glycoprotein Ib

Effects of anti-platelet glycoprotein Ib and /or IIb/IIIa autoantibodies on the size of megakaryocytes in patients with immune thrombocytopenia

✍ Y. Hasegawa; T. Nagasawa; M. Kamoshita; T. Komeno; T. Itoh; H. Ninomiya; T. Abe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

French recommendations for clinical drug

French recommendations for clinical drug trials in cognitive disorders of the elderly

✍ Dr. Bernard Michel; Roland Sambuc; Jean-Claude Scotto 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## Abstract A consensus conference on the topic of clinical drug trials in cognitive disorders of the elderly was held in Marseille on January 28–29, 1993. At the end of this conference, several recommendations were made. Drugs used in trials must be chosen according to solid neurobiological eviden

ASCPRO Recommendations for the Assessmen

ASCPRO Recommendations for the Assessment of Fatigue as an Outcome in Clinical Trials

✍ Andrea M. Barsevick; Charles S. Cleeland; Donald C. Manning; Ann M. O'Mara; Bryc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Change in Platelet Factor 3 as a Means o

Change in Platelet Factor 3 as a Means of Demonstrating Immune Reactions Involving Platelets: Its Use as a Test for Quinidine-Induced Thrombocytopenia

✍ Herbert I. Horowitz; Herbert I. Rappaport; Robert C. Young; MlTSU M. FUJIMOTO 📂 Article 📅 1965 🏛 Elsevier Science 🌐 English ⚖ 715 KB